Genpact Limited (NYSE:G) Shares Sold by Pzena Investment Management LLC

Pzena Investment Management LLC reduced its position in Genpact Limited (NYSE:G - Free Report) by 37.1% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 732,142 shares of the business services provider's stock after selling 431,717 shares during the quarter. Pzena Investment Management LLC owned 0.42% of Genpact worth $36,885,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in G. Atlas Capital Advisors Inc. boosted its stake in shares of Genpact by 55.8% during the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after purchasing an additional 216 shares in the last quarter. Stifel Financial Corp boosted its stake in shares of Genpact by 1.0% during the fourth quarter. Stifel Financial Corp now owns 30,821 shares of the business services provider's stock valued at $1,324,000 after purchasing an additional 291 shares in the last quarter. Fifth Third Bancorp boosted its stake in shares of Genpact by 9.5% during the first quarter. Fifth Third Bancorp now owns 3,461 shares of the business services provider's stock valued at $174,000 after purchasing an additional 299 shares in the last quarter. KBC Group NV boosted its stake in shares of Genpact by 4.7% during the first quarter. KBC Group NV now owns 7,266 shares of the business services provider's stock valued at $366,000 after purchasing an additional 324 shares in the last quarter. Finally, Callan Capital LLC boosted its stake in shares of Genpact by 2.9% during the first quarter. Callan Capital LLC now owns 12,312 shares of the business services provider's stock valued at $620,000 after purchasing an additional 351 shares in the last quarter. 96.03% of the stock is currently owned by institutional investors.

Genpact Stock Performance

NYSE G traded down $0.09 on Friday, reaching $45.37. 792,344 shares of the company's stock traded hands, compared to its average volume of 1,423,061. The firm has a market cap of $7.93 billion, a price-to-earnings ratio of 15.48, a P/E/G ratio of 1.96 and a beta of 0.94. The stock has a 50 day moving average price of $43.69 and a 200-day moving average price of $47.08. Genpact Limited has a fifty-two week low of $32.18 and a fifty-two week high of $56.76. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.45 and a current ratio of 2.45.

Genpact (NYSE:G - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, beating analysts' consensus estimates of $0.80 by $0.04. Genpact had a net margin of 10.88% and a return on equity of 22.35%. The company had revenue of $1.21 billion during the quarter, compared to analysts' expectations of $1.21 billion. During the same quarter in the previous year, the company earned $0.73 earnings per share. The firm's revenue for the quarter was up 7.4% on a year-over-year basis. Equities research analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, September 11th will be given a $0.17 dividend. The ex-dividend date of this dividend is Thursday, September 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.50%. Genpact's dividend payout ratio (DPR) is 23.21%.

Analyst Ratings Changes

A number of equities research analysts recently commented on G shares. Needham & Company LLC reissued a "buy" rating and set a $50.00 target price on shares of Genpact in a research report on Monday, June 30th. Mizuho increased their target price on shares of Genpact from $48.00 to $51.00 and gave the company a "neutral" rating in a research report on Tuesday, July 1st. Robert W. Baird decreased their target price on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. Wall Street Zen raised shares of Genpact from a "buy" rating to a "strong-buy" rating in a report on Friday, June 6th. Finally, Deutsche Bank Aktiengesellschaft began coverage on shares of Genpact in a report on Thursday. They issued a "hold" rating and a $47.00 price target for the company. Five research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, Genpact currently has an average rating of "Moderate Buy" and a consensus target price of $49.75.

Insider Activity

In other Genpact news, Director Nicholas C. Gangestad purchased 2,000 shares of the stock in a transaction that occurred on Tuesday, May 13th. The shares were purchased at an average cost of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the transaction, the director owned 2,000 shares of the company's stock, valued at $87,940. The trade was a ∞ increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. 3.07% of the stock is currently owned by company insiders.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.